Ignite Creation Date:
2024-05-06 @ 1:20 PM
Last Modification Date:
2024-10-26 @ 1:12 PM
Study NCT ID:
NCT03995212
Status:
TERMINATED
Last Update Posted:
2023-07-03
First Post:
2019-06-19
Brief Title:
Study to Evaluate the Safety and Efficacy of Oral CR845 Difelikefalin in Patients With Primary Biliary Cholangitis PBC and Moderate-to-Severe Pruritus
Sponsor:
Cara Therapeutics Inc
Organization:
Cara Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-19
First Submit QC Date:
June 19 2019
Study First Post Date:
2019-06-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2023-06-28
Disp First Submit QC Date:
June 28 2023
Disp First Post Date:
2023-07-03
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-06-28
Last Update Post Date:
2023-07-03
Last Update Post Date Type:
ACTUAL